21st century innovations in cutting-edge technologies have led to
discovery of novel genetic, immunology and cell biological mechanisms
underlying biology and parthenogenesis of diseases. A special revolution
has been made by this in diagnosis, prognosis and treatment of
hematological malignancies specifically leukemia. A large number of
molecular genetic assays have been developed that help in selection of
appropriate drugs and clinical protocols for leukemia patients, leading
to patient-tailored treatment with higher clinical outcomes and fewer
drug side-effects. In this era of genomic medicine, basic genetic
testing had become need of every clinic and hospital. This book provides
an account of classical and novel genetic abnormalities in different
types of leukemia and their clinical implication. It provides standard
clinically validated protocols for detection of classical genetic
aberrations in leukemia. It also provides an up-to-date account of
mutations associated with different types of hematological malignancies.